CAS: 91476-80-1; 5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine

该化合物是具有双环结构,包括imidazole和pyrazine环的杂交有机化合物,具有饱和框架,有助于其稳定性和独特的化学特性,通常无色可粉黄黄色液体或固体,视其形态和纯度而定.氮原子在其结构中的存在具有基本性和潜在的再活动性,使其具有各种化学应用,包括制药和农用化学.其分子结构允许与生物系统进行可能的相互作用,这可能导致各种药理活动.此外,5,6,7,8-Tetra hymididazo[1,2,a] Pyrazine可能在极溶剂中表现出溶解性,影响其化学反应和配方的行为.与许多含氮的乙型循环一样,它也可能参与协调化学,形成与金属离子的复合体.

结构式图片

相似化合物

1187830-84-7 345311-03-7 735266-95-2

欧盟法规

C&L通报

上下游产品

CAS号274-79-3 吲哚[1,2-A]吡嗪 | CAS号1351991-50-8 7-benzyl-5,6,7,... | CAS号345311-03-7 7-B°C-5,6,7,8-四...

合成工艺路线路线简述

  • 274-79-3 = 91476-80-1 [标题:Reaction Conditions
    标题:N-Nitro And N-Nitroso Derivatives In 5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine Series: Synthesis And Determination By Proton Nmr Spectroscopy Of The Z- And E-Configurations
    作者:Bonnet,Pierre Antoine; Et Al
    参考文献:Journal Of Chemical Research 日期:1984 卷标:(2)]

    2032-35-1 + 5049-61-6 = 91476-80-1
    反应条件:1.1 Reagents: Hydrochloric Acid Catalysts: Lithium Chloride Solvents: Tetrahydrofuran,Water; 12 H,25 °C1.2 Reagents: Triethylamine Solvents: Ethanol; 48 H,Reflux2.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Methanol; 12 H,50 Atm,40 °C
    标题:Synthesis Of Imidazo[1,2-A]Pyrazine And Imidazo[1,2-A]Pyrimidine Derivatives
    作者:Borisov,A. V.; Et Al
    参考文献:Chemistry Of Heterocyclic Compounds (New York 日期:2013 卷标:49(5) 页码:704-711]

    274-79-3 = 91476-80-1
    反应条件:1.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Methanol; 12 H,50 Atm,40 °C
    标题:Synthesis Of Imidazo[1,2-A]Pyrazine And Imidazo[1,2-A]Pyrimidine Derivatives
    作者:Borisov,A. V.; Et Al
    参考文献:Chemistry Of Heterocyclic Compounds (New York 日期:2013 卷标:49(5) 页码:704-711]

    5049-61-6 = 91476-80-1
    反应条件:1.1 Solvents: 1-Butanol,Water; 30 H,110 °C2.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Methanol; 12 H,50 Atm,40 °C
    标题:Synthesis Of Imidazo[1,2-A]Pyrazine And Imidazo[1,2-A]Pyrimidine Derivatives
    作者:Borisov,A. V.; Et Al
    参考文献:Chemistry Of Heterocyclic Compounds (New York 日期:2013 卷标:49(5) 页码:704-711]

    17157-48-1 + 5049-61-6 = 91476-80-1 [标题:Reaction Conditions
    标题:N-Nitro And N-Nitroso Derivatives In 5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine Series: Synthesis And Determination By Proton Nmr Spectroscopy Of The Z- And E-Configurations
    作者:Bonnet,Pierre Antoine; Et Al
    参考文献:Journal Of Chemical Research 日期:1984 卷标:(2)
7-Benzyl-5,6,7,8-Tetrahydro-Imidazo[1,2-A]Pyrazine置于palladium 10% On Activated Carbon 甲酸,盐酸体系中,用 甲醇,水 作为反应溶剂,化学反应 7.0H,反应生成 5,6,7,8-四氢咪唑并[1,2-A]吡嗪
参考文献:Inhibitors Of Jnk
标题:Inhibitors Of Jnk
摘要:公式i的化合物或其药用盐,其中:其中m,N,P,Q,X,Y,Z,A,R1,R2,R3,R4,R5和y6如本文所定义.本文披露的化合物和组合物可用于调节jnk的活性并治疗与jnk活性相关的疾病.

海关参考信息

专利信息


专利号:US-2025091989-A1
优先权日:2023-09-19
标 题 :Small molecule protein synthesis modulators
发明人:GYGI DAVID; BAHMANYAR SOGOLE SAMI; HAMANN LAWRENCE
权利人:INTERDICT BIO INC
摘要:The present disclosure provides compounds of the formulae herein (e.g., Formula (I)), and pharmaceutically acceptable salts thereof, which are useful for modulating protein synthesis (e.g., modulating synthesis of BCL-2, MYC, CCND1, MCL-1, ALK, KRAS-G12D). The present disclosure also provides pharmaceutical compositions and kits comprising the compounds, or pharmaceutically acceptable salts thereof, and methods of treating or preventing diseases or disorders (e.g., diseases or disorders associated with BCL-2, MYC, CCND1, MCL-1, ALK, KRAS-G12D) by administering to a subject in need thereof the compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof.

专利号:US-9936723-B2
优先权日:2014-02-12
标题 :Process for the synthesis of substituted 1-benzyl-3-(1-(isoxazol-4-ylmethyl)-1h-pyrazol-4-yl)imidazolidine-2,4-diones
发明人:FOTSING JOSEPH R
权利人:SENOMYX INC
摘要:The present invention relates to processes and intermediates for the preparation of compounds of formula (I): n nor a salt or oxide thereof, wherein Alk, M1, M2, R1, R2, R3, R4, R5, R6, R7, and n are as described herein. The present invention also relates to compounds of formula (I) and composition comprising a compound of formula (I). Also disclosed is a method of altering or improving the taste of a composition that includes adding to the composition at least one compound of formula (I), in an amount effective to obtain a modified composition having altered or improved taste relative to an otherwise identical composition lacking said compound.

专利号:US-2022118123-A1
优先权日:2019-02-22
标 题 :Combination of ar antagonists and targeted thorium conjugates
发明人:HAMMER STEFANIE; HAGEMANN URS BEAT; HAENDLER BERNARD; LEJEUNE PASCALE; ZITZMANN-KOLBE SABINE; SCHATZ CHRISTOPH; KARLSSON JENNY
权利人:BAYER AG; BAYER AS
摘要:The present invention covers combinations of at least two components, component A and component B, comprising component A being PSMA-TTC, and component B being an antiandrogen selected form AR antagonists such as from cyproterone acetate, bicalutamide, flutamide, nilutamide, enzalutamide, apalutamide, darolutamide or keto-darolutamide, or an AR degrader such as ARV-110, or an ARN-terminal domain binder such as EPI-506, or an antisense oligonucleotide that reduces AR expression such as EZN-4176 or AZD-5312, or an androgen synthesis inhibitor such as abiraterone, particularly abiraterone acetate, seviteronel, galeterone, orteronel or ketoconazole, or a dual AR antagonist and androgen synthesis inhibitor such as ODM-204. Another aspect of the present invention covers the use of such combinations as described herein for the preparation of a medicament for the treatment or prophylaxis of a disease, particularly for the treatment of a hyper-proliferative disease.

专利号:US-10968173-B2
优先权日:2016-07-07
标题:Thiocarbonylthio compounds as chain transfer agents suitable for raft polymerization
发明人:COCHRAN ERIC W; HERNANDEZ NACU; FORRESTER MICHAEL; HOHMANN AUSTIN
权利人:UNIV IOWA STATE RES FOUND INC
摘要:The present invention relates to a compound having the structure of formula (I), wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 are as described herein. The present invention also relates to a process for the preparation of a compound of formula (I) and to a process for the synthesis of a polymer using the compound of formula (I) through controlled free radical polymerization.

专利号:US-11149065-B2
优先权日:2017-04-07
标 题:One-bead-two-compound macrocyclic library and methods of preparation and use
发明人:CAI JIANFENG; SHI YAN
权利人:UNIV SOUTH FLORIDA
摘要:A one-bead-two-compound combinatorial synthesis technique provides libraries of macrocyclic peptidomimetic compounds and compositions with use as ligands for the Ephrin type-A receptor 2 (EphA2). The one-bead-two-compound technique and libraries of macrocyclic compounds are useful as research tools in drug discovery and/or to treat or prevent a range of diseases or disorders.

专利号:US-2021403993-A1
优先权日:2020-06-30
标题 :Catalytically controlled sequencing by synthesis to produce scarless dna
发明人:PUGLIESE KAITLIN; PEISAJOVICH SERGIO; MANDELL JEFFREY; MCDONALD SETH
权利人:ILLUMINA INC
摘要:The present disclosure relates to methods comprising (a) contacting a polymerase with a template polynucleotide and a plurality of free nucleotides, wherein the template polynucleotide is hybridized to a complementary polynucleotide comprising a 3′ end overhung by a 5′ terminal fragment of the template polynucleotide, and the plurality of free nucleotides comprise a compound Formula (I); wherein said contacting occurs under a complexation condition, the complexation condition effective to form a complex but not effective to form polymerization, wherein the complex comprises the polymerase, the template polynucleotide, the complementary polynucleotide, and one of the plurality of free nucleotides that is complementary to a first nucleotide of the 5′ terminal fragment of the template polynucleotide; (b) detecting a signal from the fluorescent label; and (c) exposing the complex to a polymerization condition.
济南大宇化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jinandayuchem.com
企业联系电话:0531-87153728👤
📞济南大宇化工有限公司 ⚠️参考联系方式
联系人:徐经理
电话:0531-87153728
手机:13805401165
传真:0531-87922099
邮箱:xufeng192@126.com xufeng192@jinandayuchem.com
通信地址: 济南市天桥区新材料交易产业园区西副楼
邮编: 250022
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:济南市天桥区新材料交易产业园区西副楼
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1007/s10593-013-1301-6
摘要:Borisov AV, Tolmachev AA, Zavada OA, Zhuravel’ IA, Kovalenko SN. Synthesis of imidazo[1,2-a]pyrazine and imidazo[1,2-a]pyrimidine derivatives. Chemistry of Heterocyclic Compounds. 2013 Aug 04;49(5):704–11. doi: 10.1007/s10593-013-1301-6.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知